[1]
“Activation of MIPEP Using CRISPR-Cas9 for Mitochondrial Stability and Telomere Preservation: A Novel In Silico Approach to Age-related Type-II Diabetes Treatment and Ageing”, JPEHSS, vol. 3, no. 3, pp. 126–148, Sep. 2025, doi: 10.63163/jpehss.v3i3.678.